| Net Cash Provided by (Used in) Operating Activities |
-1.44K |
USD |
+99.7% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
1.65K |
USD |
-99.7% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
300M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
29.8M |
shares |
+47% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
208K |
USD |
+27.4% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
98.9K |
USD |
+70065% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
923K |
USD |
+56.6% |
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
923K |
USD |
+56.6% |
Q3 2024 |
FY 2024 |
| Depreciation |
458 |
USD |
0% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
923K |
USD |
+56.6% |
Q3 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
25M |
USD |
+30.4% |
Q2 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
62.5K |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Expense |
16.1K |
USD |
|
Q2 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |